Glatiramer
Glatiramer is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Glatiramer Acetate. Available dosage forms: powder, injection, solution.
Drug Details
- Generic Name
- Glatiramer
- Brand Names
- Glatiramer Acetate
- Application Number
- ANDA206936
- Sponsor
- Ambiopharm, Inc.
- NDC Codes
- 2
- Dosage Forms
- POWDER, INJECTION, SOLUTION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- GLATIRAMER, GLATIRAMER ACETATE
Indications and Usage
1 INDICATIONS AND USAGE Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Glatiramer acetate injection is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults ( 1 ).